What is Marsh & Mclennan's earnings per share (EPS)?

Marsh & Mclennan (MRSH) reported diluted earnings per share of $8.43 for fiscal year 2025. This represents a 3.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Marsh & Mclennan Financials

MRSH

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Marsh & Mclennan (MRSH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 19 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MRSH FY2025 2026-04-22

Cash-rich, low-capex operations fund payouts while acquisition-driven balance-sheet growth temporarily lifts leverage and interest costs.

In the acquisition-heavy year, goodwill rose to $23.3B alongside $8.8B of investing outflow, pointing to balance-sheet growth driven by deals rather than internal capital build. The following year, free cash flow reached $5.0B while debt-to-equity eased to 1.2x, suggesting those acquired assets did not make the business materially more capital-hungry and that deleveraging can come from internal cash generation.

That is an asset-light cash model: operating cash flow was $5.3B against only $291M of capex. With free cash flow margin at 18.5% versus net margin at 15.4%, reported profit is not being soaked up by maintenance spending.

Core operating efficiency held near the low-23% range even after the acquisition step-up, so scale benefits were not erased by integration costs. But interest expense climbed to $960M as net margin narrowed to 15.4%, showing that recent pressure came more from financing structure than from weaker day-to-day operations.

Financial Health Signals

Financial Profile 60/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Marsh & Mclennan's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Marsh & Mclennan has an operating margin of 23.1%, meaning the company retains $23 of operating profit per $100 of revenue. This strong profitability earns a score of 74/100, reflecting efficient cost management and pricing power. This is down from 23.8% the prior year.

Growth

Marsh & Mclennan's revenue grew 10.3% year-over-year to $27.0B, a solid pace of expansion. This earns a growth score of 48/100.

Leverage

Marsh & Mclennan carries a low D/E ratio of 1.20, meaning only $1.20 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 78/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Marsh & Mclennan's current ratio of 1.10 is below the typical benchmark, resulting in a score of 17/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Marsh & Mclennan converts 18.5% of revenue into free cash flow ($5.0B). This strong cash generation earns a score of 69/100.

Returns

Marsh & Mclennan earns a strong 27.2% return on equity (ROE), meaning it generates $27 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 75/100. This is down from 30.0% the prior year.

Altman Z-Score Grey Zone

2.71

Marsh & Mclennan scores 2.71, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Piotroski F-Score Neutral

6/9

Marsh & Mclennan passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

1.27x

For every $1 of reported earnings, Marsh & Mclennan generates $1.27 in operating cash flow ($5.3B OCF vs $4.2B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

6.5x

Marsh & Mclennan earns $6.5 in operating income for every $1 of interest expense ($6.2B vs $960.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$27.0B

YoY+10.3%

5Y CAGR+9.4%

10Y CAGR+7.7%

Marsh & Mclennan generated $27.0B in revenue in fiscal year 2025. This represents an increase of 10.3% from the prior year.

EBITDA

$6.6B

YoY+6.4%

5Y CAGR+11.6%

10Y CAGR+9.7%

Marsh & Mclennan's EBITDA was $6.6B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 6.4% from the prior year.

Net Income

$4.2B

YoY+2.5%

5Y CAGR+15.6%

10Y CAGR+10.0%

Marsh & Mclennan reported $4.2B in net income in fiscal year 2025. This represents an increase of 2.5% from the prior year.

EPS (Diluted)

$8.43

YoY+3.1%

5Y CAGR+16.4%

10Y CAGR+11.0%

Marsh & Mclennan earned $8.43 per diluted share (EPS) in fiscal year 2025. This represents an increase of 3.1% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$5.0B

YoY+25.5%

5Y CAGR+10.5%

10Y CAGR+12.3%

Marsh & Mclennan generated $5.0B in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 25.5% from the prior year.

Cash & Debt

$2.7B

YoY+12.1%

5Y CAGR+5.2%

10Y CAGR+6.9%

Marsh & Mclennan held $2.7B in cash against $18.3B in long-term debt as of fiscal year 2025.

Dividends Per Share

$3.43

YoY+12.5%

Marsh & Mclennan paid $3.43 per share in dividends in fiscal year 2025. This represents an increase of 12.5% from the prior year.

Shares Outstanding

484M

YoY-1.4%

5Y CAGR-1.0%

10Y CAGR-0.8%

Marsh & Mclennan had 484M shares outstanding in fiscal year 2025. This represents a decrease of 1.4% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

23.1%

YoY-0.7pp

5Y CAGR+5.3pp

10Y CAGR+6.1pp

Marsh & Mclennan's operating margin was 23.1% in fiscal year 2025, reflecting core business profitability. This is down 0.7 percentage points from the prior year.

Net Margin

15.4%

YoY-1.2pp

5Y CAGR+3.7pp

10Y CAGR+3.0pp

Marsh & Mclennan's net profit margin was 15.4% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.2 percentage points from the prior year.

Return on Equity

27.2%

YoY-2.8pp

5Y CAGR+5.4pp

10Y CAGR+2.9pp

Marsh & Mclennan's ROE was 27.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 2.8 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$2.0B

YoY+123.6%

10Y CAGR+3.7%

Marsh & Mclennan spent $2.0B on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 123.6% from the prior year.

Capital Expenditures

$291.0M

YoY-7.9%

5Y CAGR-3.5%

10Y CAGR-1.1%

Marsh & Mclennan invested $291.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 7.9% from the prior year.

MRSH Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$27.0B+10.3%	$24.5B+7.6%	$22.7B+9.7%	$20.7B+4.5%	$19.8B+15.1%	$17.2B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$15.6B+11.3%	$14.0B+6.8%	$13.1B+8.5%	$12.1B+5.7%	$11.4B+12.8%	$10.1B
Operating Income	$6.2B+7.0%	$5.8B+10.1%	$5.3B+23.4%	$4.3B-0.7%	$4.3B+40.6%	$3.1B
Interest Expense	$960.0M+37.1%	$700.0M+21.1%	$578.0M+23.2%	$469.0M+5.6%	$444.0M-13.8%	$515.0M
Income Tax	$1.3B-4.3%	$1.4B+11.4%	$1.2B+23.0%	$995.0M-3.8%	$1.0B+38.4%	$747.0M
Net Income	$4.2B+2.5%	$4.1B+8.1%	$3.8B+23.1%	$3.0B-3.0%	$3.1B+55.9%	$2.0B
EPS (Diluted)	$8.43+3.1%	$8.18+8.6%	$7.53+24.7%	$6.04-1.5%	$6.13+55.6%	$3.94

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$7.6B+15.2%	$6.6B+3.8%	$6.4B-8.9%	$7.0B-1.2%	$7.1B+16.4%	$6.1B+6.5%	$5.7B-8.4%	$6.2B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$4.1B+4.9%	$3.9B+1.1%	$3.9B0.0%	$3.9B+1.2%	$3.9B+6.1%	$3.6B+5.5%	$3.4B-0.3%	$3.5B
Operating Income	$1.8B+43.9%	$1.2B+4.2%	$1.2B-36.0%	$1.8B-8.8%	$2.0B+75.6%	$1.1B+3.1%	$1.1B-32.5%	$1.6B
Interest Expense	$240.0M+2.1%	$235.0M-0.8%	$237.0M-2.5%	$243.0M-0.8%	$245.0M+6.1%	$231.0M+50.0%	$154.0M-1.3%	$156.0M
Income Tax	$395.0M+77.9%	$222.0M-12.3%	$253.0M-39.0%	$415.0M0.0%	$415.0M+99.5%	$208.0M-26.5%	$283.0M-33.4%	$425.0M
Net Income	$1.1B+39.6%	$821.0M+9.9%	$747.0M-38.3%	$1.2B-12.3%	$1.4B+75.3%	$788.0M+5.5%	$747.0M-33.6%	$1.1B
EPS (Diluted)	$2.36	N/A	$1.51-38.4%	$2.45-12.2%	$2.79	N/A	$1.51-33.5%	$2.27

MRSH Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$58.7B+3.9%	$56.5B+17.6%	$48.0B+8.9%	$44.1B+0.2%	$44.0B+33.2%	$33.0B
Current Assets	$23.2B+4.9%	$22.1B+1.7%	$21.7B+14.7%	$19.0B+129.4%	$8.3B+1.3%	$8.2B
Cash & Equivalents	$2.7B+12.1%	$2.4B-28.6%	$3.4B+132.9%	$1.4B-17.7%	$1.8B-16.1%	$2.1B
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$24.3B+4.4%	$23.3B+35.3%	$17.2B+6.0%	$16.3B-0.4%	$16.3B+5.2%	$15.5B
Total Liabilities	$43.4B+1.0%	$42.9B+20.4%	$35.7B+6.9%	$33.4B+1.8%	$32.8B+37.8%	$23.8B
Current Liabilities	$21.1B+7.9%	$19.5B-1.4%	$19.8B+11.0%	$17.8B+168.0%	$6.7B+1.5%	$6.6B
Long-Term Debt	$18.3B-5.7%	$19.4B+64.0%	$11.8B+5.5%	$11.2B+2.7%	$10.9B+1.3%	$10.8B
Total Equity	$15.3B+13.2%	$13.5B+9.4%	$12.4B+15.1%	$10.7B-4.2%	$11.2B+21.2%	$9.3B
Retained Earnings	$27.8B+9.7%	$25.3B+11.2%	$22.8B+12.1%	$20.3B+10.4%	$18.4B+13.0%	$16.3B

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$58.6B-0.3%	$58.7B-0.1%	$58.8B+0.4%	$58.6B+2.7%	$57.0B+0.9%	$56.5B+13.3%	$49.9B+2.6%	$48.6B
Current Assets	$23.2B+0.2%	$23.2B-2.1%	$23.7B+1.6%	$23.3B+3.9%	$22.5B+1.6%	$22.1B-0.8%	$22.3B+1.2%	$22.0B
Cash & Equivalents	$1.6B-40.0%	$2.7B+7.0%	$2.5B+49.7%	$1.7B+4.6%	$1.6B-33.1%	$2.4B+33.4%	$1.8B+8.8%	$1.7B
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$24.3B-0.3%	$24.3B+1.6%	$23.9B+0.1%	$23.9B+1.6%	$23.5B+1.0%	$23.3B+27.8%	$18.2B+4.1%	$17.5B
Total Liabilities	$43.7B+0.8%	$43.4B-0.1%	$43.4B+2.0%	$42.6B-0.4%	$42.7B-0.5%	$42.9B+19.4%	$36.0B+2.7%	$35.0B
Current Liabilities	$20.9B-0.7%	$21.1B-0.2%	$21.1B+8.8%	$19.4B-1.9%	$19.8B+1.3%	$19.5B-0.4%	$19.6B+3.9%	$18.9B
Long-Term Debt	$18.9B+3.2%	$18.3B0.0%	$18.3B-3.4%	$19.0B+0.5%	$18.9B-2.9%	$19.4B+57.6%	$12.3B+0.4%	$12.3B
Total Equity	$14.8B-3.3%	$15.3B-0.3%	$15.4B-3.9%	$16.0B+12.0%	$14.3B+5.4%	$13.5B-2.5%	$13.9B+2.3%	$13.6B
Retained Earnings	$28.0B+1.0%	$27.8B+3.0%	$26.9B-0.5%	$27.1B+4.7%	$25.9B+2.3%	$25.3B+3.2%	$24.5B-0.2%	$24.6B

MRSH Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$5.3B+23.0%	$4.3B+1.0%	$4.3B+22.9%	$3.5B-1.5%	$3.5B+4.0%	$3.4B
Capital Expenditures	$291.0M-7.9%	$316.0M-24.0%	$416.0M-11.5%	$470.0M+15.8%	$406.0M+16.7%	$348.0M
Free Cash Flow	$5.0B+25.5%	$4.0B+3.7%	$3.8B+28.3%	$3.0B-3.7%	$3.1B+2.5%	$3.0B
Investing Cash Flow	-$845.0M+90.4%	-$8.8B-522.5%	-$1.4B-66.7%	-$850.0M+27.0%	-$1.2B-46.8%	-$793.0M
Financing Cash Flow	-$4.6B-204.0%	$4.5B+498.1%	-$1.1B-7.0%	-$1.0B+19.4%	-$1.3B-40.2%	-$925.0M
Dividends Paid	$1.7B+12.3%	$1.5B+16.6%	$1.3B+14.1%	$1.1B+10.9%	$1.0B+8.8%	$943.0M
Share Buybacks	$2.0B+123.6%	$900.0M-21.7%	$1.1B-41.0%	$1.9B+68.2%	$1.2B	$0

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$688.0M-131.8%	$2.2B+3.8%	$2.1B+24.6%	$1.7B+368.6%	-$622.0M-131.8%	$2.0B+2.3%	$1.9B+57.4%	$1.2B
Capital Expenditures	$62.0M-41.0%	$105.0M+45.8%	$72.0M+22.0%	$59.0M+7.3%	$55.0M-27.6%	$76.0M+4.1%	$73.0M-8.8%	$80.0M
Free Cash Flow	-$750.0M-136.5%	$2.1B+2.3%	$2.0B+24.7%	$1.6B+338.1%	-$677.0M-136.0%	$1.9B+2.2%	$1.8B+62.0%	$1.1B
Investing Cash Flow	-$104.0M+80.1%	-$523.0M-130.4%	-$227.0M-87.6%	-$121.0M-565.4%	$26.0M+100.3%	-$7.6B-1845.3%	-$393.0M+5.3%	-$415.0M
Financing Cash Flow	$114.0M+105.6%	-$2.0B-172.0%	-$753.0M+55.6%	-$1.7B-1128.3%	-$138.0M-102.2%	$6.3B+537.0%	-$1.4B-176.7%	-$519.0M
Dividends Paid	$440.0M-0.9%	$444.0M-0.2%	$445.0M+9.9%	$405.0M0.0%	$405.0M+0.5%	$403.0M-0.2%	$404.0M+14.8%	$352.0M
Share Buybacks	$755.0M-25.2%	$1.0B+151.2%	$402.0M+34.0%	$300.0M0.0%	$300.0M	$0-100.0%	$300.0M0.0%	$300.0M

MRSH Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	23.1%-0.7pp	23.8%+0.6pp	23.2%+2.6pp	20.7%-1.1pp	21.8%+4.0pp	17.8%
Net Margin	15.4%-1.2pp	16.6%+0.1pp	16.5%+1.8pp	14.7%-1.1pp	15.9%+4.2pp	11.7%
Return on Equity	27.2%-2.8pp	30.0%-0.4pp	30.4%+2.0pp	28.4%+0.4pp	28.0%+6.2pp	21.8%
Return on Assets	7.1%-0.1pp	7.2%-0.6pp	7.8%+0.9pp	6.9%-0.2pp	7.1%+1.0pp	6.1%
Current Ratio	1.10-0.0	1.13+0.0	1.10+0.0	1.06-0.2	1.240.0	1.24
Debt-to-Equity	1.20-0.2	1.44+0.5	0.96-0.1	1.04+0.1	0.97-0.2	1.17
FCF Margin	18.5%+2.2pp	16.3%-0.6pp	16.9%+2.5pp	14.4%-1.2pp	15.7%-1.9pp	17.6%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	23.1%+4.6pp	18.5%+0.1pp	18.4%-7.8pp	26.2%-2.2pp	28.4%+9.6pp	18.8%-0.6pp	19.4%-6.9pp	26.4%
Net Margin	15.1%+2.6pp	12.4%+0.7pp	11.8%-5.6pp	17.4%-2.2pp	19.6%+6.6pp	13.0%-0.1pp	13.1%-5.0pp	18.1%
Return on Equity	7.7%+2.4pp	5.4%+0.5pp	4.9%-2.7pp	7.6%-2.1pp	9.7%+3.9pp	5.8%+0.4pp	5.4%-2.9pp	8.3%
Return on Assets	2.0%+0.6pp	1.4%+0.1pp	1.3%-0.8pp	2.1%-0.3pp	2.4%+1.0pp	1.4%-0.1pp	1.5%-0.8pp	2.3%
Current Ratio	1.110.0	1.10-0.0	1.12-0.1	1.20+0.1	1.140.0	1.130.0	1.14-0.0	1.17
Debt-to-Equity	1.28+0.1	1.200.0	1.190.0	1.19-0.1	1.32-0.1	1.44+0.5	0.89-0.0	0.91
FCF Margin	-9.9%-41.1pp	31.2%-0.5pp	31.6%+8.5pp	23.1%+32.7pp	-9.6%-40.6pp	31.0%-1.3pp	32.3%+14.0pp	18.2%

Frequently Asked Questions

What is Marsh & Mclennan's annual revenue?

Marsh & Mclennan (MRSH) reported $27.0B in total revenue for fiscal year 2025. This represents a 10.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Marsh & Mclennan's revenue growing?

Marsh & Mclennan (MRSH) revenue grew by 10.3% year-over-year, from $24.5B to $27.0B in fiscal year 2025.

Is Marsh & Mclennan profitable?

Yes, Marsh & Mclennan (MRSH) reported a net income of $4.2B in fiscal year 2025, with a net profit margin of 15.4%.

What is Marsh & Mclennan's EBITDA?

Marsh & Mclennan (MRSH) had EBITDA of $6.6B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Marsh & Mclennan have?

As of fiscal year 2025, Marsh & Mclennan (MRSH) had $2.7B in cash and equivalents against $18.3B in long-term debt.

What is Marsh & Mclennan's operating margin?

Marsh & Mclennan (MRSH) had an operating margin of 23.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Marsh & Mclennan's net profit margin?

Marsh & Mclennan (MRSH) had a net profit margin of 15.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Marsh & Mclennan pay dividends?

Yes, Marsh & Mclennan (MRSH) paid $3.43 per share in dividends during fiscal year 2025.

What is Marsh & Mclennan's return on equity (ROE)?

Marsh & Mclennan (MRSH) has a return on equity of 27.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Marsh & Mclennan's free cash flow?

Marsh & Mclennan (MRSH) generated $5.0B in free cash flow during fiscal year 2025. This represents a 25.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Marsh & Mclennan's operating cash flow?

Marsh & Mclennan (MRSH) generated $5.3B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Marsh & Mclennan's total assets?

Marsh & Mclennan (MRSH) had $58.7B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Marsh & Mclennan's capital expenditures?

Marsh & Mclennan (MRSH) invested $291.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Marsh & Mclennan buy back shares?

Yes, Marsh & Mclennan (MRSH) spent $2.0B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Marsh & Mclennan have outstanding?

Marsh & Mclennan (MRSH) had 484M shares outstanding as of fiscal year 2025.

What is Marsh & Mclennan's current ratio?

Marsh & Mclennan (MRSH) had a current ratio of 1.10 as of fiscal year 2025, which is considered adequate.

What is Marsh & Mclennan's debt-to-equity ratio?

Marsh & Mclennan (MRSH) had a debt-to-equity ratio of 1.20 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Marsh & Mclennan's return on assets (ROA)?

Marsh & Mclennan (MRSH) had a return on assets of 7.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Marsh & Mclennan's Altman Z-Score?

Marsh & Mclennan (MRSH) has an Altman Z-Score of 2.71, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Marsh & Mclennan's Piotroski F-Score?

Marsh & Mclennan (MRSH) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Marsh & Mclennan's earnings high quality?

Marsh & Mclennan (MRSH) has an earnings quality ratio of 1.27x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Marsh & Mclennan cover its interest payments?

Marsh & Mclennan (MRSH) has an interest coverage ratio of 6.5x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Marsh & Mclennan?

Marsh & Mclennan (MRSH) scores 60 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.